International Journal of Technology Assessment in Health Care

Article	Citations
PP114 The Influence Of Implicit Factors On The Health Technology Assessment Deliberative Process: A Survey In Five European Countries	181
PP150 The Role Of Expert Consensus In UK Guidance: Patient Selection For Hydrogel Spacer Use During Prostate Cancer Radiotherapy	42
PP53 Applying The VALIDATE Approach To Frame The Assessment Of Integrated Care Management In Aortic Valve Stenosis	31
PP97 Recommendations For Generating South African Health-Related Quality Of Life Data For Cost-Utility Analyses	27
PD35 Mortality And Risk Factors Associated With Dialysis Patients With COVID-19 In A Brazilian Supplementary Health Service	20
OP42 Increasing Access To Real-World Data To Move From Health Technology Assessment To Health Technology Management	20
PD09 Comparing Long-term Costs Associated With Intraocular Lens Selection And Nd:YAG Laser Capsulotomy In The UK: A Cost-Consequence Analysis	20
PP47 Modelling Non-small Cell Lung Cancer Treatment: Predicted and Observed Impact Of Immunotherapy In The Netherlands	20
PP23 Lost In Translation? The Differences In The Use Of Real-World Evidence Across Key Markets	19
OP312 Developing A Tool-kit For Assessment Of Autism Spectrum Disorder	18
OP123 The Use Of Surrogate Outcomes In National Institute For Health And Care Excellence (NICE) Highly Specialised Technology Evaluations: A Review Of Published Guidance	18
OP92 Impact Of Real-World Evidence On Health Technology Assessment And National Guidance For Interventional Procedures: A UK Perspective	18
PP94 Pandemic Preparedness: EUnetHTA COVID-19 Rapid Response With “Rolling Collaborative Reviews (RCR)”	17
OP82 Positron Emission Tomography Combined With Computed Tomography Using 18F-Sodium Fluoride	17
PP97 How Health Technology Agencies Estimate Target Population Size For Medical Devices: The Example Of Spinal Cord Stimulation	16
OP128 Uncertainties In The Cost-Effectiveness Analysis Of Onasemnogene Abeparvovec For Spinal Muscular Atrophy Type 1	15
PP105 Efficacy, Effectiveness And Safety Of Letermovir For Prophylaxis Of Cytomegalovirus Infection And Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation	15
PP11 Patient Involvement In Drug Evaluations To Inform Funding Decisions: A Singapore Case Study	15
OP19 Exploring The Environment/Capacity Of South African Citizen Actors To Contribute To Health Technology Assessment Processes, Policy Development And Institutionalization	13
PP38 Designing A Training And Capacity Building Pathway In Patient Involvement	13
PP79 Publication Trends Of Network Meta-analyses In Europe And Asia: A Focus On Cardiovascular Disease	13
OP60 Methodological Guidance And Doctrine Of The French National Authority For Health For Economic Evaluation	12
Trial-based economic evaluation of the BrainACT study: acceptance and commitment therapy for anxiety and/or depressive symptoms after acquired brain injury	12
PD208 Optimal Scheme For Molecular Diagnosis Of BRCA1/2 Gene Mutations In Patients With Breast Cancer In Poland - Cost-Utility Analysis	11
PD137 Reviewing The Health Technology Assessment And Regulatory Policy Landscape On Acceptability Standards For Real-World Evidence - Initial Findings	11

PD149 Comparison Of The Draft European Union Health Technology Assessment Template With Germany’s AMNOG Template	11
OP76 Cost-Effectiveness Of Offering Human Papillomavirus Self-Sampling To Non-Attendees Of Organized Primary Cervical Cancer Screening In Germany	10
OD12 Large Language Models As Powerful Tools In Health Technology Assessment	10
PP56 National Immunization Technical Advisory Groups Are Essential For Successful Implementation Of The European Health Technology Assessment Regulation	10
PP07 One Bad Apple Can Spoil The Barrel: Are We Effectively Evaluating Software As A Medical Device?	10
PD129 Extension Of An Influenza Vaccination Program To Include Those Aged 50 To 64 Years: A Rapid Health Technology Assessment Approach	10
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis	9
PP92 Enhancing Patient Engagement In Health Technology Assessment: Identification Of Barriers, Facilitators, And Proposals For Improvement	9
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies	9
OP25 Rapid Molecular Tests For Detecting Multidrug-Resistant Microorganisms: An Overview Of Systematic Reviews Within A Living Evidence Project	9
Mapping frameworks for synthesizing qualitative evidence in health technology assessment	9
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review	9
PD10 Cost Effectiveness Analysis Of Etranacogene Dezaparvovec Versus Factor IX Prophylaxis In Adult Men With Hemophilia B From Brazil	9
A model-based study to estimate the health and economic impact of health technology assessment in Thailand	8
Acknowledgments	8
Health technology assessment in traditional and complementary medicine: a scoping review of international activity and examples of acupuncture	8
Methods and criteria for the assessment of orphan drugs: a scoping review	8
Development and implementation of a value framework for rapid health technology assessment reports: enhancing evidence-informed decision making in resource-constrained settings	8
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report	8
Reframing Early Health Technology Assessment Through a Lifecycle Lens: Commentary on “Defining Early Health Technology Assessment: Building Consensus Using Delphi Technique”	8
Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum	8
PP165 Bridging The Gap Of Health Services During The COVID-19 Pandemic Through Telemedicine	8
PP118 Cyclic Mental Health Technology Assessment with Priority Setting And Involving Stakeholders - A Case Report From The Netherlands	7
PP259 Invisible Resilience: The Value Of Medical Technology In Reducing Population And Health Systems’ Vulnerability To COVID-19.	7
PP149 A Multidimensional And Multistakeholder Approach: Assessing Ethical, Legal, Organizational, Social or Patient-centered (ELSI+) for Telemedicine In Neurological Diseases	7
PP09 Use Of Real-World Evidence For Managing Health Technologies Throughout The Life Cycle Of Transcatheter Aortic Valve Interventions	7
OP181 Adapting Evidence To Produce A Health Technology Assessment Of Mammography Screening: An Example From The West Bank	7
A first exploration of the economic consequences of an autonomous surgical robot for lateral skull base surgery: an early health technology assessment	6
OP80 Generating Patient Preference Evidence For Health Technology Assessment: A Sustainable Roadmap	6
OD11 Application Of Natural Language Processing To Predict Final Recommendation Of Brazilian Health Technology Assessment Reports	6
OP176 Integrating Real-world Compliance In The Assessment Of Left Atrial Appendage Closure Versus Anticoagulation Therapy In Non-valvular Atrial Fibrillation	6
OP90 Optimizing Health Technology Assessment And Appraisal For Orphan Drug Reimbursement: Experiences And Tools For Improvement	6
Acceptability of Manufacturer-Proposed Utility Values for NICE Cancer Medicine Appraisals: Analysis of Manufacturers’ Information Sources	6
Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect	6
Integrating organizational impacts into health technology assessment (HTA): an analysis of the content and use of existing evaluation frameworks	6
PD71 Survival Outcomes And Adherence To Defined Daily Doses Of Imiglucerase: A 16-Year Brazilian Cohort Study In Gaucher Disease	6
The role of health economics within health technology assessment: past, present, and future – an Austrian perspective	6
PD203 Comparison Of Health Technology Assessment Methodologies Across Australia, Canada, New Zealand And The United Kingdom: Implications For Future Collaboration	6
PP09 Fecal Immunochemical Tests For Patients With Symptoms Suggestive Of Colorectal Cancer: A Systematic Review And Multiple-Threshold Meta-Analysis	6
Health technology assessment and healthcare environmental sustainability: Prioritizing effort and maximizing impact	6
Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling	5
OP167 An Analysis Of Medication Exclusion Reports In The Health Technology Assessment Process For The Brazilian Unified Health System	5
Decision making for early surgical technology adoption into Canada’s healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities	5
OP27 Impact Of Generic Entry Of Pharmaceuticals On Drug Prices In Australia	5
OP129 The Use Of A Text-Mining Screening Tool For Systematic Review Of Treatments For Relapsed/Refractory Diffuse Large B-Cell Lymphoma	5
Toward including environmental sustainability in Health Technology Assessment	5
Use of surrogate endpoints in health technology assessment: a review of selected NICE technology appraisals in oncology	5
OP126 Clinical And Economic Evaluation Of The Effectiveness Of Cerebrolysin® In Neurological Patients With Post-Stroke Complications In Kazakhstan	5
A review of HTA guidelines on societal and novel value elements	5
The HTAi early HTA definition: a welcome milestone, and what must follow	5

OP46 The Decision Uncertainty Toolkit: Risk Measures And Visual Outputs To Support Health Technology Decision-making During Public Health Crises	5
PP146 Seeing Eye-To-Eye on Real-World Evidence: Are Guidance from Japan and China Consistent with Recommendations from REALISE in Asia?	5
Economic evaluation of genomic/genetic tests: a review and future directions	5
OP199 From Pilot Studies To System-Wide Innovation: Challenges And Opportunities For Clinical Decision Support Systems (CDSS) Implementation In Australia	4
OP163 Applying A Local Economic Evaluation Framework To Make Evaluations More Relevant For Local Decision Makers	4
PP111 Reimbursement And Payment Models: A Survey Of Stakeholders’ Current Experiences And Future Outlook Within The Dutch Policy Setting	4
The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey	4
OP44 Does The Health Economic Modelling Structure Matter? An External Validation Of Three Approaches Commonly Used In Obesity Modelling	4
Acceptability of self-administered antigen test for COVID-19 in the Philippines	4
Perception of non-layperson advisory committee members on the application of a discrete choice experiment instrument to patients and advisory committee members: a qualitative study	4
OP218 Searching Preprint Repositories For COVID-19 Therapeutics Using A Semi-Automated Text-Mining Tool	4
Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders’ perspectives	4
Optimizing red blood cell transfusion practices in the intensive care unit: a multi-phased health technology reassessment	4
PP275 Incorporating Quality-Of-Care Indicators In Health Economic Modelling: A Case-Study On Surgical Site Infections In Cardiac Surgery	4
OP51 Use Of Real-World Data In Cost-effectiveness Analysis Of Sequential Biologic Treatment For Rheumatoid Arthritis	4
OP65 An Overview Of Participatory Approaches, Stakeholders, Methods, Topics and Challenges In Medical Device Development: A Scoping Review	4
Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach	4
PD22 Exploratory Analysis of a Brazilian Real-World Open Database Applied to Prostate Cancer	4
OP105 Gaps, Challenges And Priorities For Neurodegenerative Disease Research And Health Technology Assessment	4
A value framework for lymphoma therapies based on MACBETH method	4
PD33 Development And Validation Of A Machine Learning-Based Prediction Model For COVID-19 Diagnosis Using Patients’ Metabolomic Profile Data	4
Patient-based evidence: its role in decision making on end-of-life, orphan, and ultra-orphan medicines	4
OP136 A Comparison Of Health Technology Assessment Recommendations In Australia, Canada, And England: Is There Opportunity For Further Alignment?	4
Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum	4
PP70 Mapping Of Health Technology Assessment In China: A Comparative Study Between 2016 And 2021	4
Patient perspectives on continuous glucose monitoring system (CGMS) for diabetes in Malaysia: a vital voice in health technology assessment (HTA) informing decision-making	4
Results of health technology assessments of orphan drugs in Germany—lack of added benefit, evidence gaps, and persisting unmet medical needs	4
PD05 Novel Non-Thermal Ablation Technology For The Treatment Of Atrial Fibrillation	4
PP195 Cost Utility Of Transcatheter Aortic Valve Implantation For Patients With Inoperable Severe Aortic Stenosis In Brazil	4
Building capacity in horizon scanning, early awareness, and disinvestment: a framework for education and training	4
PP34 Impact Of The COVID-19 Pandemic On Depression Incidence And Healthcare Service Use Among Patients With Depression	3
OD14 Harmonization Of HTA For Digital Health Technologies: The EU-Funded European Digital Health Technology Assessment Project	3
PP55 Health Technology Assessment Scoping Definition For Health Regulation	3
PD133 Exploring Real-World Data Based Financing Models For Lung Cancer Immunotherapy In The Czech Republic	3
PD177 The Effect Of COVID-19 On Cancer Screening In Brazil, Canada, And The USA: A Cross-National Study	3
Advancing cooperation in Health Technology Assessment in Europe: insights from the EUnetHTA 21 project amidst the evolving legal landscape of European HTA	3
A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK	3
PD231 A New Way Of Identifying And Selecting Health Technology Assessment Topics: Using Social Media And Citizen Involvement	3
PD42 Should Antibiotics Be Used To Treat Recurrent Otitis Media In Children? Updating A Recommendation	3
PD186 Treat-To-Target In Gout: Are Private General Practitioners In Malaysia Riding The Evidence-Based Wave?	3
OP70 Implementation Of An Online Consultation Hub To Facilitate Consumer Engagement In Health Technology Assessment Processes	3
Analysis of consumer comments into PBAC decision-making (2014–9)	3
A review of audiovisual telemedicine utilization and satisfaction assessment during the COVID-19 pandemic	3
PP57 Outcomes Model For Assessing Strategies Improving In Vitro Fertilization Birth Rates	3
PD124 Genicular Artery Embolization For The Treatment Of Knee Osteoarthritis: A Systematic Review And Meta-analysis	3
PD199 Global Collaboration Post-Brexit: Do Project Orbis And The Access Consortium Improve Access In The UK Compared With Europe?	3
OP01 Impact Of Cost Heterogeneity On Assessing The Value Of Gene Therapies	3
OD39 Evaluation Of Sustainability And Environmental Impact Measures In Health Technology Assessment Of Medical Technologies In Europe: Starting An Important Journey	3
Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment	3
PD07 Cost-Effectiveness Of Direct Oral Anticoagulants In Chinese Patients With Non-Valvular Atrial Fibrillation	2
PD119 Interventions To Improve Long COVID Symptoms: A Systematic Review Of Randomized Controlled Trials	2
PP109 Which Review Is Right For You? Choosing A Review Methodology	2
OP54 The Early Detection And Warning System ‘SINTESIS-New Technologies’: A Horizon Scanning Experience In Spain	2
OP83 Joining Efforts To Improve Patient Involvement In Health Technology Assessment: The Case Of The RedETS Patient Interest Group	2
OP74 Analysis Of Literature And Research Foci In Overdiagnosis Based On Citespace	2
Expanding access to sodium-glucose cotransporter 2 inhibitors (SGLT2i) in the Ministry of Health Malaysia – a multiple HTA approach	2
IOATLAS: scanning across the medical horizon	2
PD96 Are Continuous Noninvasive Blood Pressure Monitoring Devices Accurate Enough To Replace Invasive Monitoring? A Rapid Review	2
OP69 Are Artificial-Intelligence-Based Literature Reviews Accepted By Health Technology Assessment Bodies?	2
PP87 Glecaprevir/pibrentasvir (Maviret®) Remains A Cost-effective Treatment For Chronic Hepatitis C Virus Infection After Changes To The Treated Population	2
Lifecycle evaluation of medical devices: supporting or jeopardizing patient outcomes? A comparative analysis of evaluation models	2
PP37 Guidance On Using Hospital-Based Real-World Evidence In Health Technology Assessments For Oncology	2
OP79 Incorporating Environmental Impacts Into Health Technology Assessment: An Examination Of Potential Approaches And Challenges	2
PP120 Fluorescent In Situ Hybridization (FISH) Vs Conventional Cytogenetic (CC) For Detecting High-Risk Genetic Mutations In Multiple Myeloma	2
OP279 Data Protection In The European Union Post-General Data Protection Regulation (GDPR): A Barrier Or An Enabler Of Pharmaceutical Innovation?	2
PD60 The Importance Of Systematic Reviews Addressing Questions Of Prevalence In Health Technology Assessment	2
PP108 Multidimensional Analysis Of Peristeen Plus Medical Device	2
OP81 Do Sustainable Healthcare Principles Inform Guidance Development? An Exemplary Case Study In Respiratory Care	2
Implementing a sandbox approach in health technology assessment: benefits and recommendations	2
The relative importance of severity and rarity criteria in health resource allocation: an umbrella review	2
Response to heterogeneity of tests and platforms in economic evaluations: synthetic model adoption; derivatives of transferable practice	2
OD33 Assessment Tool For MHealth Apps To Manage Depression (EvalDepApps Project)	2
Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape	2
PD50 Does The New Healthcare Reform Improve Job Satisfaction Among Village Clinic Doctors In China? A Meta-Analysis	2
PP222 Efficacy And Safety Of Foot Reflexology	2
PP41 COVID-19 Modeling To Support Decision Making In Brazil: A Scoping Review	2
PP33 Molecular Markers For The Detection Of Clinically Significant Prostate Cancer	2
OP13 Improving Case Finding For Celiac Disease In Children And Adults: Evidence Synthesis And Economic Modeling	2
OD30 Clinician-Driven Health Technology Assessment: National Cancer Medicines Review For Off-Label Uses And On-Label Off-Patent Uses In NHSScotland	2
OP67 Considerations Of Treatment Novelty In Health Technology Assessment	2

PD56 Conceptual Issues In The Valuation Of Health States In Children	2
PP22 A Lifecycle Approach To The Use Of Real-World Evidence In HTA Submissions And Resubmissions: A Decade’s Experience	2
Calibration of transition probabilities to model survival of adjuvant trastuzumab for early breast cancer in Indonesia	2
PD61 Thromboprophylaxis After Major Orthopedic Surgeries: Health Technology Assessment To Promote Access To Oral Anticoagulants	2
OP31 Monitoring Of The Budget Impact Determinants Of Incorporated Technologies For Rare Diseases In The Brazilian Health System	2
PP53 Potential Cost-Effectiveness And Innovation Headroom Of A More Accurate Companion Diagnostic For PD-L1 In Non-Small-Cell Lung Cancer	2
OP244 Tools And Experiences To Facilitate Effective Patient Participation In Health Technology Assessment	2
PP129 Health Technology Assessment Adaptation: Pharyngolaryngeal Biopsies (OLB) For People with Suspected Head and Neck Cancer in the Outpatient Setting	2
INAHTA member agency stories of engaging, adaptable, and impactful HTA	1
A systematic literature review of revealed preferences of decision-makers for recommendations of cancer drugs in health technology assessment	1
OP168 Costs And Effectiveness Of Whole Exome Sequencing (WES) In Patients With Unsolved Rare Disease Through The Diagnostic Pathway	1
PP71 Lessons Learned During Analyses Of Appropriate Hearing Care: Building Bridges Between Patient Organizations, Health Professionals And Insurance Companies	1
PD35 A Decade In Review: Assessing The Quality Of Clinical Evidence For Oncology Drugs Submitted To A National Health Technology Assessment Agency	1
PD25 Innovation In Facial Palsy Treatment: The Costs And Benefits Of Telerehabilitation Introduced Into Physical Therapy Pathways	1
PP91 Developing A Re-assessment Process For Non-medicine Health Technologies In Wales	1
PD93 Uncertainty Metric To Guide PICOS Assessment And Evidence Synthesis Planning For Joint Clinical Assessment Submission	1
PP63 Perspectives Of Physical And Organic Disability Organizations On Health Technology Assessment Processes	1
PP81 Barriers To Implementation Of Health Technology Assessment	1
OP11 Differences And Similarities In Past Health Technology Assessments In Beneluxa Initiative Countries	1
OP51 Improving Childhood Cancer Management And Financing In Ghana: Results From Stakeholder Mapping and Analysis	1
OP127 The Cost Effectiveness Of Anti-Vascular Endothelial Growth Factor Treatments For Age-Related Macular Degeneration In The Italian Healthcare Setting	1
PP14 Value-Based Pricing For Advanced Therapy Medicinal Products: Emerging Affordability Solutions	1
Incorporating healthcare access and equity in economic evaluations: a scoping review of guidelines	1
PP49 Cost Of Cardiac Implantable Electronic Device (CIED) Infections In Australia: A Private And Public Sector Payer Perspective	1
PP153 Efficacy And Safety of Onasemnogene Abeparvovec For The Treatment Of Patients With Spinal Muscular Atrophy Type 1: Meta-Analysis	1
PP127 Early Health Technology Assessment (HTA) Of Medical Technologies To Inform Subsidy Decision-making In Singapore	1
OD37 How The PICOTS-ComTeC Framework For Digital Health Interventions Can Be Useful For Health Technology Assessment	1
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis	1
PP43 Budget Impact Analysis Of Next-Generation Sequencing Coverage In Taiwan’s National Health Insurance	1
The UK early access to medicines scheme: uptake, approvals, and reimbursement	1
Tisagenlecleucel for relapsed/refractory acute lymphoblastic leukemia in the Irish healthcare setting: cost-effectiveness and value of information analysis	1
OP43 Incorporating Mathematical Modeling To Improve Accuracy Of Budget Impact Analysis: Using Screening For Hepatitis C As An Example	1
OD17 Future Health And Economic Burden Of Cardiovascular Disease In Type 2 Diabetes In Australia From 2021 To 2031	1
Health technology assessment for oral health in the past decade: a scoping review	1
Values, principles, strategies, and frameworks underlying patient and public involvement in health technology assessment and guideline development: a scoping review	1
OD41 Conducting Systematic Reviews On Rare Diseases: Lessons Learned From The European Reference Networks Guidelines Programme	1
Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report	1
OP93 Informing Efficient Diagnostic Monitoring Pathways Using Prospective Cohort Data: A Case Study In Neovascular Age-Related Macular Degeneration	1
OP172 International Collaboration For Translating The Peer Review Of Electronic Search Strategies (PRESS) Checklist: A Harmonized Approach	1
OP46 Assessing The Quality Of Pharmacoeconomic Evaluations About Type 2 Diabetes Mellitus Drugs In National Reimbursement Drug List	1
OP11 Cost-Effectiveness Of Atezolizumab Plus Chemotherapy As A First-Line Treatment For Metastatic Non-Squamous Non-Small Cell Lung Cancer	1
PP21 Examining Clinical Evidence: Incorporation Of Medications For Ultra-Rare Diseases – Descriptive Analysis Of Conitec Reports (2012 to 2022) – Brazil	1
OP06 Percutaneous Transforaminal Endoscopic Discectomy: From Insufficient Evidence To Reimbursement	1
PP219 Combining Healthcare Solutions For Cataract Surgery. An Incremental Benefit Analysis From The Perspective Of The Russian Healthcare System	1
OP47 New Health Technology Assessment Framework For Digital Health Technologies	1
PP231 Safety, Effectiveness And Economic Analysis Of Exercise Intervention For Prevention Of Cognitive And Functional Deterioration In Hospitalized Patients	1
PP100 Improving The Assessment Of Effectiveness For Digital Applications Using The B Statistic: Using WtsWrng As A Case Study	1
National health technology assessment in Turkiye after a decade: are key principles followed?	1
PP38 Immersion in water during childbirth: A survey to the Spanish National Health System	1
OP83 Diagnostic Accuracy And Cost Effectiveness Of Automated Ankle Brachial Pressure Index Measurement For Peripheral Arterial Disease In People With Leg Ulceration	1
OP35 Suitability Of Preference Methods Across The Medical Product Lifecycle: A Multicriteria Decision Analysis	1
PD26 Overscreening For Older Women In Cervical And Breast Cancer Screening In Japan	1
OP248 A Minimum Data-Set For Left Ventricular Assist Device On Destination Therapy: Cross-Border Collaboration Pilot On Real World Data	1
PP153 The Economic And Fiscal Impact Of Public Health Programs For Diabetic Patients In Italy	1
PD155 RedETS Horizon Scanning: Impact In The Decision-Making Process	1
PP85 The Cost-Effectiveness Of The Anti-COVID Vaccination Campaign In The Italian Healthcare Setting	1
PD173 Semi-Automation Of Systematic Literature Review Title And Abstract Screening Using Text Mining And Classification Techniques	1
PP12 Challenges In Assessing The Efficacy Of Non-Pharmacological Measures In The Context Of The COVID-19 Pandemic	1
OP34 Horizon Scanning A Matter Of Collaboration. A Description Of The Processes Of I-HTS Member Organizations	1
PD185 Is The Incorporation Of Medications For Ultrarare Diseases In Brazil Predominantly Driven By Costs? A Shift In Paradigm	1
PD116 Development Of A Value Framework For The Appropriate Prescription Of High-Cost Cancer Drugs In A Cancer Center	1
Transferability of a EUnetHTA relative effectiveness assessment to low- and middle-income countries setting	1
OP88 Translating Patient Reported Measure Score Into Specific Outcomes From The Patient Perspective–Example Using Health Assessment Questionnaire-Disability Index	1
PP13 Development Of Recommendations And Proposal For A Value-Based Managed Entry Agreement For Italian Setting	1
PP84 Evaluation Of The Evidence Level Of Scrambler Therapy For Musculoskeletal Pain Relief: A Systematic Literature Review	1
PP106 Twenty Years Of Orphan Medicines Regulation: Have Treatments Reached Patients In Need Across Europe And Canada?	1
OP102 Towards Universal Health Coverage: Health Technology Assessment Roadmap Development In The Emirate Of Abu Dhabi Involving The Whole Ecosystem	1
OD26 Comparing Health Technology Developers’ Proposed Indication To An Estimated Indication Generated By An International Horizon Scanning Database	1
OP05 The Role Of Conditional Reimbursement In The Lifecycle Approach	1
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France	1
PP24 Creating A Comprehensive Open-Access Health Technology Assessment (HTA) Policy Research Database Through Automated Data Extraction From HTA Reports	1
OP74 Assessing Public Confidence Towards COVID-19 Vaccines Through Social Media Insights Leveraged Using Artificial Intelligence Techniques	1
PP59 Do Patient Contributions Matter? A Thematic Document Analysis Of NICE Ultra-Rare Disease Appraisals	1
OP56 Hospital-Based Health Technology Assessment: Barriers And Facilitators In France, Hungary, Italy, Kazakhstan, Poland, Switzerland, And Ukraine	1
PP140 Economic Evaluation Of Several Vaccination Strategies Against Rotavirus In Spain	1
PD32 Cost-Utility Of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres For Chemotherapy-Refractory Metastatic Colorectal Cancer In Brazil	1
Priority setting for health technology adoption at the national level: Lessons learned over 25 years’ experience	1
PP99 Positron Emission Tomography Combined With Computed Tomography (PET/CT) Using 11-C Methionine (11C-MET)	1
OP98 Improving Patient Involvement In Health Technology Assessments: Is It Enough To Train Just The Patients?	1
OP61 Target Trial Emulation To Determine The Population-Level Cost-Effectiveness Of Multigene Panel Sequencing For Advanced Melanoma	1
PP71 Hospitalization Costs Associated With Advanced Non-Small Cell Lung Cancer In China: Real World Evidence From Jiangsu	1
PD90 Use Of Medicinal Herbs In Natura By Pregnant Women In The Amazon Region	1
OP115 Scoping Meta-Review On Methods Used To Assess Artificial Intelligence-Based Medical Devices For Heart Failure	1
OP35 Early Access To Medicinal Products In France: A Positive Evaluation Two Years Into The New Framework	1
Increasing the impact of budget impact analysis: incorporating uncertainty for decision-makers in small markets	1
PD18 Cytomegalovirus Prophylaxis With Valganciclovir For HIV-Immunosuppressed Patients: Cost Effectiveness And Budget Impact Analysis From The Brazilian Healthcare System Perspective	1
PD39 First Approach For Assessing Statistical Significance In Industry Funded Matching-Adjusted Indirect Comparison Studies: A Scoping Review	1
OP316 Patients’ Testimonials In The National Committee For Health Technology Incorporation In Brazilian Public Health System (Conitec) Meetings	1
European Network for Health Technology Assessment’s Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics	1
OP45 Incorporation Of The Tetravalent Dengue Vaccine In The Brazilian Public Health System: A Cost–Benefit Analysis	1
PD32 Incorporating Environmental Factors Into Health Technology Assessment Submissions: A Scoping Review	1
PD01 Using ELISA Tests For Monitoring Response To Anti-TNFs In Rheumatoid Arthritis: Findings From A NICE Health Technology Assessment	0
OP24 Impact Of Patient Input On Cancer Drug Funding Recommendations In Canada	0
PD95 Enhancing Clinical Practice Guideline Development In Brazil: A Tutoring Program For Health Technology Assessment Centers	0
PD29 Systematic Review With Meta-analysis Of Pharmacokinetic Parameters Of Tyrosine Kinase Inhibitors Used In Chronic Myeloid Leukemia	0